Operating Lease, Right-of-Use Asset in USD of Transcode Therapeutics, Inc. from Q1 2023 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Transcode Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q1 2023 to Q4 2024.
  • Transcode Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2024 was $37,731, a 92% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Transcode Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $37,731 -$443,963 -92% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 $150,240 -$439,972 -75% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $261,730 -$436,047 -62% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $372,210 -$432,187 -54% 31 Mar 2024 10-Q 15 May 2024 2023 Q3
Q4 2023 $481,694 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 $590,212 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $697,777 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $804,397 31 Mar 2023 10-Q 15 May 2023 2023 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.